Nursing care
Bladder Cancer nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Bladder cancer nursing starts with recognising painless haematuria as the classic presenting sign, since the absence of pain is exactly why patients delay seeking care. Nursing priorities include urinary assessment, monitoring for clot retention, supporting patients through cystoscopy or cystectomy, and teaching stoma or catheter care where needed.
What it is and why it happens
Bladder cancer arises most often from the urothelium lining the bladder wall, with urothelial (transitional cell) carcinoma accounting for the large majority of cases. Smoking is the single biggest risk factor, roughly doubling risk and implicated in a substantial proportion of cases, because carcinogens concentrated in urine sit in prolonged contact with the bladder lining. Occupational exposure to aromatic amines, used historically in dye, rubber and textile industries, and chronic bladder irritation from long-term catheter use or schistosomiasis in endemic regions are also recognised drivers.
Most bladder cancers are diagnosed as non-muscle-invasive, confined to the mucosa or submucosa, which carries a good prognosis but a high recurrence rate, so lifelong surveillance is standard rather than optional. Muscle-invasive disease carries a much higher risk of metastasis and typically needs more aggressive treatment, including radical cystectomy. This split between non-invasive and invasive disease shapes almost every downstream nursing decision, from teaching to follow-up frequency.
How it presents — what you will actually see
Painless haematuria is the presenting sign, and painless is what makes patients wait. Blood in the urine that doesn't hurt reads to most people as less serious than pain, so it gets attributed to a urinary tract infection, dehydration, or ignored altogether for weeks or months before a clinician sees it. Gross haematuria may be intermittent, which reinforces the false reassurance: it clears up, so patients assume it resolved on its own.
Beyond haematuria, patients may report urgency, frequency, or dysuria that mimics a resistant urinary infection, particularly with carcinoma in situ. Advanced disease can bring flank pain from ureteric obstruction, pelvic pain, unintentional weight loss, or lower limb oedema from lymphatic or venous compression. Any adult with unexplained haematuria, especially with a smoking history, needs urological referral rather than repeated courses of empirical antibiotics.
Nursing assessment priorities
Take a thorough haematuria history: was it painless, gross or microscopic, intermittent or constant, and did it prompt the patient to seek care immediately or delay. This history directly informs urgency of referral and is often the detail that gets lost when haematuria is assumed to be infective. Take a smoking history in pack-years, since it shapes both risk stratification and the teaching conversation about cessation.
Assess for clot retention risk in anyone with active gross haematuria, including bladder fullness, suprapubic discomfort, and difficulty voiding. Review occupational history for exposure to industrial chemicals, and ask about prior pelvic radiation or chronic catheter use as contributing factors. Before cystoscopy or resection, confirm baseline continence and sexual function, since these are the domains most affected by more extensive surgery and need a pre-treatment reference point.
Interventions and what to do first
If a patient presents with gross haematuria and suspected clot retention, the first priority is establishing a large-bore three-way catheter for continuous bladder irrigation to clear clots and prevent obstruction. Monitor irrigation fluid input and output closely, and escalate if output falls short of input, which suggests retained clot or a blocked line rather than resolving bleeding.
For patients undergoing transurethral resection of bladder tumour, prioritise post-procedure monitoring for bleeding, bladder perforation signs such as abdominal pain and distension, and adequate urine output. For those proceeding to radical cystectomy with urinary diversion, coordinate stoma education preoperatively where possible, since patients cope better when they've seen and handled equipment before surgery rather than meeting it for the first time postoperatively. For non-muscle-invasive disease, support adherence to intravesical BCG or chemotherapy instillation schedules, since gaps in this schedule raise recurrence risk.
Complications to watch for
Watch for clot retention and bladder tamponade in anyone with active haematuria, which can progress to acute urinary retention and hydronephrosis if unaddressed. After BCG instillation, monitor for systemic BCG infection, a rare but serious complication presenting with fever, chills, and malaise that requires prompt antimicrobial treatment rather than being dismissed as a normal instillation reaction.
Post-cystectomy, monitor for stoma complications including ischaemia, retraction, or peristomal skin breakdown, alongside the standard surgical risks of infection and ileus. Ureteric strictures and metabolic derangements from urinary diversion, such as hyperchloraemic acidosis with certain diversion types, can develop over the longer term and should be flagged at follow-up rather than only assessed in the immediate postoperative window. In advanced disease, ureteric obstruction causing hydronephrosis and renal impairment is a key complication to monitor via renal function and urine output.
Patient teaching before discharge
Teach patients to report any recurrence of haematuria immediately rather than waiting to see if it resolves, directly countering the delay pattern that painless bleeding tends to produce. Reinforce that clear urine does not mean the underlying issue is gone, since intermittent bleeding is part of the disease's natural pattern.
For patients discharged with a catheter or stoma, provide hands-on training in care and troubleshooting, with written instructions and a contact number for problems out of hours. Strongly encourage smoking cessation and offer referral to cessation support, since continued smoking raises recurrence risk. Confirm the patient understands the surveillance cystoscopy schedule, particularly for non-muscle-invasive disease where regular follow-up is lifelong, and make sure the first appointment is booked before they leave rather than left to the patient to arrange.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our renal and genitourinary practice questions are the closest set to what this page covers.
Common questions
Why do patients delay seeking care for bladder cancer symptoms?
Because the classic presenting sign, gross haematuria, is usually painless, patients often assume it's minor or misattribute it to infection or dehydration. Intermittent bleeding that clears up on its own reinforces this false reassurance. This delay pattern is exactly why any unexplained haematuria warrants prompt urological referral.
Is microscopic haematuria as significant as gross haematuria in bladder cancer?
Microscopic haematuria still warrants investigation, particularly in patients with risk factors like a smoking history or occupational chemical exposure, though it's picked up incidentally rather than prompting the patient to seek care themselves. It should not be dismissed as a benign finding without further workup.
What is the nursing priority for clot retention after a bladder tumour resection?
Establish or maintain continuous bladder irrigation via a three-way catheter to clear and prevent clots, and monitor irrigation input against output closely. A mismatch suggesting retained clot or obstruction needs prompt escalation to avoid painful distension and renal backpressure.
How often does non-muscle-invasive bladder cancer recur?
Recurrence rates are high, with a substantial proportion of patients experiencing at least one recurrence, which is why lifelong cystoscopic surveillance is standard rather than a limited course of follow-up. This is a key teaching point for patient expectations at discharge.
What are signs of a systemic reaction to BCG bladder instillation?
Fever, chills, malaise, and joint pain beyond the first 24 to 48 hours after instillation can indicate systemic BCG infection rather than a typical local reaction. This needs prompt medical assessment and often antimicrobial treatment, and further instillations should be held until reviewed.